
    
      Intravitreal Bevacizumab has been used by retinal specialist in treatment many retinal
      diseases. Although it not approved by FDA for treatment. In many In vitro studies, its showed
      saftey in the eyes especially for corneal endothelium cells, that important cells to keep
      cornea clear. This study use Confoscan-Corneal confocal microsope to evaluate corneal
      endothelium before and after intravitreal Bevacizumab injection in routine retinal disease at
      6 month follow up.
    
  